Abstract.
The gene of the p85α regulatory subunit of phosphatidylinositol (PI) 3-kinase gives rise to several splice variants. We hypothesized that the expression of p85α splice variants may be altered in skeletal muscle from subjects with type 2 diabetes mellitus. Skeletal muscle biopsies were obtained from nine type 2 diabetic and eight healthy men, matched for age, body mass index (BMI) and physical fitness. PI 3-kinase activity in skeletal muscle following in vitro insulin stimulation was reduced in subjects with type 2 diabetes. p85α mRNA was elevated fourfold in type 2 diabetic as compared to healthy control subjects (P<0.05). p85α mRNA abundance was positively correlated with plasma insulin concentration (P<0.01) and serum glucose concentration (P<0.01). Despite this, protein levels of p85α, p55α, and the novel human p50α were not altered in type 2 diabetic subjects. Thus, although gene expression of full-length p85α is increased in skeletal muscle from type 2 diabetics, this is not reflected by increased protein levels. Therefore, defects in PI 3-kinase activity are likely due to impaired activation of the enzyme rather than changes in protein expression of the isoforms of the regulatory subunit.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Tsuchida, H., Björnholm, M., Fernström, M. et al. Gene expression of the p85α regulatory subunit of phosphatidylinositol 3-kinase in skeletal muscle from type 2 diabetic subjects. Pflugers Arch - Eur J Physiol 445, 25–31 (2002). https://doi.org/10.1007/s00424-002-0907-9
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00424-002-0907-9